Identification of a novel CCDC22 mutation in a patient with severe Epstein?Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia
Identification of a novel CCDC22 mutation in a patient with severe Epstein?Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia
复制标题
重度 Epstein?Barr 病毒相关噬血细胞性淋巴组织细胞增多症和侵袭性自然杀伤细胞白血病患者中新型 CCDC22 突变的鉴定
DOI:
10.1007/s12185-019-02595-0
复制
发表时间:
2019
影响因子:
2.1
通讯作者:
Tamura S
中科院分区:
文献类型:
--
作者:
Yamashita Y;Nishikawa A;Iwahashi Y;Fujimoto M;Sasaki I;Mishima H;Kinoshita A;Hemmi H;Kanazawa N;Ohshima K;Imadome KI;Murata SI、Yoshiura KI;Kaisho T;Sonoki T;Tamura S
Aggressive natural killer cell leukemia (ANKL) is a rare neoplasm characterized by the systemic infiltration of Epstein–Barr virus (EBV)-associated NK cells, and rapidly progressive clinical course. We report the case of a 45-year-old man with intellectual disability who developed ANKL, and describe the identification of a novel genetic mutation ofcoiled-coil domain-containing 22(CCDC22). He presented with persistent fever, severe pancytopenia, and hepatosplenomegary. Following bone marrow aspiration, numerous hemophagocytes were identified. High EBV viral load was detected in NK cells fractionation by qPCR. The initial diagnosis was EBV-related hemophagocytic lymphohistiocytosis (EBV–HLH). A combination of immunosuppressive drugs and chemotherapy was administered, but was unsuccessful in controlling the disease. Therefore, he was treated with HLA-matched related allogeneic hematopoietic stem cell transplantation. However, his condition deteriorated within 30 days, resulting in fatal outcome. Autopsy revealed many EBV-infected NK cells infiltrating major organs, consistent with ANKL. Furthermore, whole-exome sequencing identified a novel missense mutation of theCCDC22gene (c.112G>A, p.V38M), responsible for X-linked intellectual disability (XLID). CCDC22 has been shown to play a role in NF-κB activation. Our case suggests thatCCDC22mutation might be implicated in pathogenesis of EBV–HLH and NK-cell neoplasms as well as XLID via possibly affecting NF-κB signaling.